Geneia, an analytics and emerging technology leader in transforming healthcare delivery, announced today that Rochester, N.Y.-based Excellus BlueCross BlueShield has agreed to partner with Geneia to deliver value-based analytics and insights to the health plan’s 1.5 million members using the company’s Theon® platform.
“We are committed to improving the quality and affordability of healthcare and have chosen to partner with Geneia to drive insights to achieve just that,” said Excellus BlueCross BlueShield CEO Chris Booth. “We were impressed with Geneia’s capability to drive effective interventions and the breadth of the Theon® solution that we expect will grow with our needs.”
Geneia has in particular highlighted its track record of helping other customers succeed in value-based cost and quality arrangements through the use of the Theon® platform. Such notable achievements with improved outcomes and member satisfaction include:
“We are excited to be working with Excellus BlueCross BlueShield,” said Geneia CEO Mark Caron, CHCIO, FACHE. “This upstate New York health plan is taking a strong leadership role to improve collaboration with its provider partners and ensuring the sustainability of healthcare in the community. We look forward to helping them achieve their goals.”